Prognostic Significance of C-Reactive Protein–Albumin Score for Cachexia, Severe Malnutrition, and Survival in Patients with Cancer

Abstract Background This study aimed to develop and validate the C-reactive protein-albumin score (CAZ score) using a multicenter cohort, evaluating its prognostic value for cancer patients and its association with severe malnutrition and cachexia. Methods The analysis included a multicenter cohort of 6,492 cancer patients, with validation in Cohort A ( n = 4,548) and Cohort B ( n = 1,944). The CAZ score was calculated by normalizing baseline C-reactive protein and albumin levels into z-scores and combining them, then stratifying into four categories (normal, mild, moderate, severe). Kaplan-Meier analysis, Cox proportional hazards models, and restricted cubic spline analysis were used to assess the CAZ score’s prognostic value for overall survival (OS). Logistic regression examined its associations with severe malnutrition and cancer cachexia, with sensitivity analysis excluding short-term mortality to test robustness. Results Kaplan-Meier analysis revealed significant stepwise differences in OS across the four CAZ score categories (71.9% vs 65.9% vs 54.9% vs 42.3%, Log-rank P < 0.001). Restricted cubic spline analysis showed a significant linear dose-response relationship between the continuous CAZ score and cancer-related mortality risk ( P < 0.001). The CAZ score-based inflammatory grading system provided significant prognostic stratification, with substantial differences in OS among patients in different inflammatory burden grade groups (85.5% vs 62.9% vs 46.9%, P < 0.001). Cox models identified the CAZ score as an independent prognostic factor for OS, with severe CAZ scores correlating to a 2.102-fold higher mortality risk compared to the normal group (95% CI: 1.872–2.360, P < 0.001). Logistic regression demonstrated a dose-dependent increase in the risk of severe malnutrition and cachexia ( P < 0.001) with higher CAZ scores. All findings were consistently replicated in the two independent validation cohorts. Conclusion The CAZ score, a novel standardized composite biomarker, effectively predicts OS in cancer patients and identifies those at high risk for severe malnutrition and cachexia.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-17
DOI
https://doi.org/10.21203/rs.3.rs-11304139/v1
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Prognostic Significance of C-Reactive Protein–Albumin Score for Cachexia, Severe Malnutrition, and Survival in Patients with Cancer

Jun Fei Chen, Yibo Chen, Hanping Shi, Yuhang Zhang et al.
2 links
Research Square
Inflammatory Biomarkers in Disease Prognosis
preprint

Prognostic Significance of C-Reactive Protein–Albumin Score for Cachexia, Severe Malnutrition, and Survival in Patients with Cancer

Jun Fei Chen, Yibo Chen, Hanping Shi, Yuhang Zhang, Lishuang Wei, 舒耀 王, 长红 徐, 诺奥 徐, 长阳 陈, 西宇 林, 海伦 谢, 太气 陈
preprint en

Abstract

Abstract Background This study aimed to develop and validate the C-reactive protein-albumin score (CAZ score) using a multicenter cohort, evaluating its prognostic value for cancer patients and its association with severe malnutrition and cachexia. Methods The analysis included a multicenter cohort of 6,492 cancer patients, with validation in Cohort A ( n = 4,548) and Cohort B ( n = 1,944). The CAZ score was calculated by normalizing baseline C-reactive protein and albumin levels into z-scores and combining them, then stratifying into four categories (normal, mild, moderate, severe). Kaplan-Meier analysis, Cox proportional hazards models, and restricted cubic spline analysis were used to assess the CAZ score’s prognostic value for overall survival (OS). Logistic regression examined its associations with severe malnutrition and cancer cachexia, with sensitivity analysis excluding short-term mortality to test robustness. Results Kaplan-Meier analysis revealed significant stepwise differences in OS across the four CAZ score categories (71.9% vs 65.9% vs 54.9% vs 42.3%, Log-rank P < 0.001). Restricted cubic spline analysis showed a significant linear dose-response relationship between the continuous CAZ score and cancer-related mortality risk ( P < 0.001). The CAZ score-based inflammatory grading system provided significant prognostic stratification, with substantial differences in OS among patients in different inflammatory burden grade groups (85.5% vs 62.9% vs 46.9%, P < 0.001). Cox models identified the CAZ score as an independent prognostic factor for OS, with severe CAZ scores correlating to a 2.102-fold higher mortality risk compared to the normal group (95% CI: 1.872–2.360, P < 0.001). Logistic regression demonstrated a dose-dependent increase in the risk of severe malnutrition and cachexia ( P < 0.001) with higher CAZ scores. All findings were consistently replicated in the two independent validation cohorts. Conclusion The CAZ score, a novel standardized composite biomarker, effectively predicts OS in cancer patients and identifies those at high risk for severe malnutrition and cachexia.

Research Square
Guangxi Medical University (CN)
Capital Medical University, China Postdoctoral Science Foundation, National Key Research and Development Program of China, Youth Science Foundation of Guangxi Medical University
Good health and well-being
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon